VYOME HOLDINGS, INC. Unrealized Gain (Loss) on Derivatives
VYOME HOLDINGS, INC. (HIND) reported Unrealized Gain (Loss) on Derivatives of $30.51 thousand for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnDerivatives · last filed 2025-11-14
- 2025-09-30: Unrealized Gain (Loss) on Derivatives 9 month $30.51K.
- 2024-09-30: Unrealized Gain (Loss) on Derivatives 9 month -$239.69K.
| Period end | Unrealized Gain (Loss) on Derivatives 9 month |
|---|---|
| 2025-09-30 | $30.51K 10-Q · filed 2025-11-14 |
| 2024-09-30 | -$239.69K 10-Q · filed 2025-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |